PatternsRadar
Sign in

BIOCONBiocon Limited

NSEF&O
364.40INR+0.75 (+0.21%)Close · 20 Nov 2026
4 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹59,386 CrMarket cap
131.4P/E (TTM)
53.1%Delivery

Filings & corporate actions

82 results filed
CSV
Next results · Q3 FY27
Expected 21 Jan 2027 – 15 Feb 2027
Estimate: filed 21–46 days after quarter end, last 5 times
Dividend
₹0.50 per share · last 3 Jul 2026
2026
  • 4 NovresultsResults · Q2 FY27 · consolidated and standalone+5.1%NSE
  • 21 OctshareholdingShareholding · 30 Sept 2026-1.5%NSE
  • 5 AugresultsResults · Q1 FY27 · consolidated and standalone+2.7%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+0.9%NSE
  • 3 JuldividendDividend · ₹0.50 per share+2.0%
  • 1 JulshareholdingShareholding · 29 Jun 20260.0%NSE
  • 8 MayresultsResults · Q4 FY26 · consolidated-0.5%NSE
  • 7 MayresultsResults · Q4 FY26 · standalone-0.5%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+0.7%NSE
  • 12 FebresultsResults · Q3 FY26 · consolidated and standalone+0.8%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025-0.4%NSE
  • 16 JanshareholdingShareholding · 14 Jan 2026-0.4%NSE
  • 6 JanshareholdingShareholding · 5 Jan 2026-1.6%NSE

Reaction to results · all yearsrose on day 0 in 28 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY274 Nov 2026+5.1%+7.7%—2.2×
Q1 FY275 Aug 2026+2.7%-1.2%-5.5%1.6×
Q4 FY267 May 2026-0.5%+12.5%+7.1%1.8×
Q3 FY2612 Feb 2026+0.8%+2.4%+0.5%1.6×
Q2 FY2611 Nov 2025+5.4%+6.5%-1.5%6.5×
Q1 FY267 Aug 2025-5.7%0.0%+0.1%1.2×
Q4 FY258 May 2025-1.4%+1.4%-1.4%2.0×
Q3 FY2531 Jan 2025+1.6%+11.2%-15.3%1.1×
Q2 FY2530 Oct 2024-1.4%+2.3%+17.0%4.9×
Q1 FY259 Aug 2024-0.6%+1.7%+11.3%2.5×
Q4 FY2416 May 20240.0%+4.5%+9.5%1.0×
Q3 FY249 Feb 2024-2.5%+6.5%+2.1%0.9×
Q2 FY2410 Nov 2023+3.3%+3.3%+4.9%0.6×
Q1 FY2411 Aug 2023-0.6%+1.5%+4.3%1.2×
Q4 FY2324 May 2023-1.3%+0.9%-1.7%1.9×
Q3 FY2315 Feb 2023+2.0%-7.6%-15.0%1.9×
Q2 FY2315 Nov 2022-0.8%-1.3%-7.0%2.0×
Q1 FY2327 Jul 2022-5.1%-2.9%-6.1%6.0×
Q4 FY2229 Apr 2022+1.2%-10.2%-11.1%1.0×
Q3 FY2221 Jan 2022+3.5%+0.8%+6.4%3.9×
Q2 FY2222 Oct 2021-0.8%+7.6%+11.1%1.5×
Q1 FY2223 Jul 2021-2.2%-2.0%-12.2%0.9×
Q4 FY2129 Apr 2021-3.6%-3.2%-1.4%2.3×
Q3 FY2122 Jan 2021-2.8%-0.6%-2.1%2.8×
Q2 FY2123 Oct 2020-3.5%-3.1%+3.9%2.2×
Q1 FY2124 Jul 2020-3.7%-0.8%-5.5%0.8×
Q4 FY2015 May 2020+1.0%+9.1%+17.2%1.3×
Q3 FY2024 Jan 20200.0%0.0%+6.8%2.9×
Q2 FY2024 Oct 2019-1.4%+7.6%+7.9%1.9×
Q1 FY2026 Jul 2019+1.4%-3.1%-4.1%3.3×
Q4 FY1910 May 2019+1.5%-2.0%-0.2%0.9×
Q3 FY1928 Jan 2019-0.1%0.0%-4.5%1.0×
Q2 FY1929 Oct 2018+2.8%+1.1%-3.2%1.0×
Q1 FY193 Aug 2018-1.6%-1.9%+7.1%0.5×
Q4 FY1815 Jun 2018-0.5%+1.7%-6.6%0.5×
Q3 FY1813 Mar 2018+0.3%-3.9%+3.6%1.0×
Q2 FY1830 Oct 2017+2.1%+14.8%+15.6%0.7×
Q1 FY1831 Jul 2017-2.1%-9.0%-12.4%0.7×
Q4 FY1717 May 2017-0.5%-5.9%+4.2%0.8×
Q3 FY1730 Jan 2017-0.9%+7.6%+9.2%0.8×
Q2 FY1724 Oct 2016-3.2%-4.7%-11.3%1.6×
Q1 FY171 Oct 2016+3.3%+1.2%-2.6%0.6×
Q4 FY1627 Apr 2016+1.2%+9.9%+15.0%1.8×
Q3 FY1622 Jan 20160.0%+0.7%-2.3%1.0×
Q2 FY1627 Oct 20150.0%+1.5%+3.2%0.5×
Q1 FY1628 Jul 2015-2.0%+1.7%-7.2%1.0×
Q4 FY159 May 2015+1.5%+3.7%+0.2%0.4×
Q3 FY1523 Jan 2015-0.9%+3.1%+3.0%1.9×
Q2 FY1527 Oct 2014-2.1%-6.1%-4.2%1.0×
Q1 FY155 Aug 2014+1.1%+1.7%+6.2%0.9×
Q4 FY1430 Apr 2014-0.8%+1.6%-9.7%0.6×
Q3 FY1423 Jan 2014-5.7%-3.3%-1.8%1.6×
Q2 FY1428 Oct 2013-0.6%+6.2%+11.8%0.7×
Q1 FY1430 Jul 2013-3.6%-3.7%+5.6%1.2×
Q4 FY1310 May 20130.0%+1.4%-0.1%0.3×
Q3 FY1325 Jan 2013+1.6%+6.7%+9.0%1.2×
Q2 FY1331 Oct 2012+2.4%+11.3%+10.5%2.5×
Q1 FY1326 Jul 2012-5.4%-3.9%-1.0%2.0×
Q4 FY124 May 2012-1.8%-6.8%-10.5%0.9×
Q3 FY1225 Jan 2012-3.4%-3.3%+3.5%2.6×
Q2 FY1220 Oct 2011-0.3%+2.2%-7.8%1.6×
Q1 FY1221 Jul 2011-2.0%-1.9%-12.9%6.2×
Q4 FY1128 Apr 2011-4.0%-7.0%-13.5%4.3×
Q3 FY1120 Jan 2011-2.0%-8.2%-11.1%6.9×
Q2 FY1122 Oct 2010+0.2%-7.2%-8.7%1.1×
Q1 FY1123 Jul 2010-3.1%-6.5%+6.2%4.8×
Q4 FY1029 Apr 2010+2.9%-1.4%-4.1%3.9×
Q3 FY1021 Jan 2010-3.7%-8.0%-8.3%2.3×
Q2 FY1022 Oct 2009+0.6%-8.4%-1.0%3.2×
Q1 FY1023 Jul 2009+3.1%+0.7%+1.0%2.2×
Q4 FY0928 Apr 20090.0%+7.6%+26.2%4.1×
Q3 FY0921 Jan 2009+1.1%-11.0%-8.0%6.6×
Q2 FY0916 Oct 2008-3.7%-6.7%-20.9%1.4×
Q1 FY0917 Jul 2008-6.7%-2.9%+5.6%7.5×
Q4 FY0822 Apr 2008+0.8%-3.0%-6.3%27.2×
Q3 FY0817 Jan 2008-1.4%-28.3%-23.9%1.2×
Q2 FY0818 Oct 2007-1.6%-2.2%+25.1%2.8×
Q1 FY0818 Jul 2007+0.1%-3.0%-5.7%6.5×
Q4 FY0719 Apr 2007-2.6%-7.5%-9.6%2.6×
Average-0.6%-0.4%-0.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+2.2%
Profit YoY-51.1%
Interest cost YoY-9.1%
Revenue QoQ+1.2%
Profit QoQ-70.7%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+8.1%+8.6%+17.8%+19.0%+17.1%+16.1%
Profit-44.0%-3.2%-7.5%-7.5%-6.8%-9.7%

Key data

Open362.90
Day range360.90 – 365.70
52-week range318.40 – 447.15
From 52w high-18.5%
RSI (14)54.1
ATR (14)8.56
Volume14.77L
Avg volume (20D)32.31L
Rel volume0.46×
Volatility (1Y)25.7%
Turnover₹53.6Cr
Traded value (NSE)₹53.6Cr
VWAP363.27
SMA 50 / 200363.05 / 389.94
Price bandNo band
MWPL used46.7%

Delivery percentage

Latest · 20 Nov 202653.1%
20-day avg46.3%
1-year avg48.8%
Percentile (own history)92nd
Range5.1–85.7%
Sessions3,629

Over the last 20 sessions BIOCON settled 46.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 48.8%, so recent sessions are running 2.5 points lower than usual. The latest session ranks higher than 92% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.14%
Dividend, trailing 12M₹0.50
Paid every year for5 yr
Shareholders3.93L · +0.1% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy129 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.21%+0.10%+10.32%-11.66%-15.42%-11.37%

Valuation

Market cap₹59,386 Cr
Market cap (NSE)₹59,386 Cr
Free-float cap₹32,852 Cr
P/E (TTM)131.4
P/E (NSE)174.2
EPS (TTM)2.77
P/B1.7
Net margin (TTM)2.6%
Other income / PBT71.5%
ROE1.5%
Debt / equity0.41
Shares outstanding162.96Cr
Listed7 Apr 2004

Ownership

Promoter44.68%
Promoter Δ QoQ0.00 pp
Public55.14%
FII8.64%
DII29.30%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)4,173.04,516.64,336.04,388.9
YoY chg+9.2%+2.3%+10.0%+2.2%
Net profit (₹ Cr)(51.8)198.6136.856.7
YoY chg-163.9%-56.8%+53.4%-57.3%
Net margin-1.2%4.4%3.2%1.3%
EPS1.070.790.870.25

Shareholding over time

By quarter

30 Sept 2026 · promoter 44.68% · public 55.14%
30 Sept 2021: promoter 60.64%31 Dec 2021: promoter 60.64%31 Mar 2022: promoter 60.64%30 Jun 2022: promoter 60.64%30 Sept 2022: promoter 60.64%31 Dec 2022: promoter 60.64%31 Mar 2023: promoter 60.64%30 Jun 2023: promoter 60.64%30 Sept 2023: promoter 60.64%31 Dec 2023: promoter 60.64%31 Mar 2024: promoter 60.64%30 Jun 2024: promoter 60.64%30 Sept 2024: promoter 60.64%31 Dec 2024: promoter 60.64%31 Mar 2025: promoter 60.64%19 Jun 2025: promoter 54.45%30 Jun 2025: promoter 54.45%30 Sept 2025: promoter 54.45%31 Dec 2025: promoter 54.45%5 Jan 2026: promoter 48.27%14 Jan 2026: promoter 44.91%31 Mar 2026: promoter 44.91%29 Jun 2026: promoter 44.68%30 Jun 2026: promoter 44.68%30 Sept 2026: promoter 44.68%
2021-092026-09
  • Promoter
  • Public and others
Promoter
44.68%
Public
55.14%
Promoter change
0.00 pp
Filed
21 Oct 2026
FII
8.64%
DII
29.30%
Promoter pledged
0.00%

Who the public is

Mutual funds
22.08%

+6.61 pp QoQ

Insurance
5.55%

-0.82 pp QoQ

FPI
8.64%

+0.50 pp QoQ

Retail ≤ ₹2L
5.88%

+0.04 pp QoQ

HNI > ₹2L
4.31%

-0.11 pp QoQ

NRI
0.63%

+0.01 pp QoQ

Bodies corporate
5.23%

-0.92 pp QoQ

Shareholders
3,93,051

+0.1% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
KIRAN MAZUMDAR-SHAWPromoter · Individual29.73%
GLENTEC INTERNATIONALPromoter · Corporate14.56%
SBI ESG EXCLUSIONARY STRATEGY FUNDMutual fund9.18%
ICICI PRUDENTIAL RETIREMENT FUND-PURE EQUITY PLANMutual fund4.07%
SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITEDCorporate3.40%
LICI NEW PENSION PLUS GROWTH FUNDInsurance2.62%
KOTAK LARGE & MIDCAP FUNDMutual fund2.57%
HDFC MUTUAL FUND - HDFC DIVIDEND YIELD FUNDMutual fund1.07%
RAVI RASENDRA MAZUMDARPromoter · Individual0.33%
DEV MAZUMDARPromoter · Individual0.06%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 5 Jul 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹0.50₹0.50
FY2025-261₹0.50₹0.50
FY2024-251₹0.50₹0.50
FY2023-241₹1.50₹1.50
FY2022-231₹0.50₹0.50
FY2019-201₹0.50₹0.50
FY2018-191₹1.00₹0.50
FY2017-181₹1.00₹0.50
FY2015-162₹10.00₹1.67
FY2014-151₹5.00₹0.83
FY2013-141₹7.50₹1.25
FY2012-131₹5.00₹0.83
Ex-dateRecord dateDeclaredAdjusted
3 Jul 2026—₹0.50₹0.50
4 Jul 2025—₹0.50₹0.50
5 Jul 2024—₹0.50₹0.50
7 Jul 2023—₹1.50₹1.50
30 Jun 2022—₹0.50₹0.50
18 Jul 2019—₹0.50₹0.50
19 Jul 2018—₹1.00₹0.50
20 Jul 2017—₹1.00₹0.50
17 Mar 2016—₹5.00₹0.83
9 Apr 2015—₹5.00₹0.83
10 Jul 2014—₹5.00₹0.83
11 Jul 2013—₹7.50₹1.25
5 Jul 2012—₹5.00₹0.83

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
6.1 years ago
Disclosures on record
1,434
43 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
2 Apr 2024KIRAN KUMAR GANDHIRAJANEmployeeSell20.0K₹52.9L264.341.59L → 1.39L0.01%-0.00 pp7(2)told 31 Mar 2024
2 Apr 2024Akhilesh NandEmployeeSell11.0K₹28.7L260.551.91L → 1.80L0.01%-0.00 pp7(2)told 30 Mar 2024
5 Mar 2024MANEESH H GHILDYALEmployeeSell5.0K₹14.2L283.0090.0K → 85.0K0.01%-0.00 pp7(2)told 4 Mar 2024
5 Mar 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.8L275.8091.0K → 90.0K0.01%-0.00 pp7(2)told 4 Mar 2024
5 Mar 2024MANEESH H GHILDYALEmployeeSell2.0K₹5.4L270.9593.0K → 91.0K0.01%-0.00 pp7(2)told 4 Mar 2024
29 Feb 2024MANEESH H GHILDYALEmployeeSell2.0K₹5.6L279.2095.0K → 93.0K0.01%-0.00 pp7(2)told 29 Feb 2024
29 Feb 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.8L277.5098.0K → 97.0K0.01%-0.00 pp7(2)told 29 Feb 2024
29 Feb 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.8L277.3596.0K → 95.0K0.01%-0.00 pp7(2)told 29 Feb 2024
29 Feb 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.8L278.5597.0K → 96.0K0.01%-0.00 pp7(2)told 29 Feb 2024
27 Feb 2024MANEESH H GHILDYALEmployeeSell2.0K₹5.4L270.451.00L → 98.0K0.01%-0.00 pp7(2)told 27 Feb 2024
27 Feb 2024MANEESH H GHILDYALEmployeeSell5.0K₹13.6L272.501.05L → 1.00L0.01%-0.00 pp7(2)told 27 Feb 2024
26 Feb 2024Gayatri NayakEmployeeSell5.0K₹13.6L271.5026.5K → 21.5K0.00%0.00 pp7(2)told 23 Feb 2024
22 Feb 2024MUKESH KAMATH KEmployeeSell5.7K₹15.5L270.0885.7K → 80.0K0.01%-0.00 pp7(2)told 22 Feb 2024
22 Feb 2024MUKESH KAMATH KEmployeeSell1.0K₹2.9L285.0086.7K → 85.7K0.01%-0.00 pp7(2)told 22 Feb 2024
22 Feb 2024MUKESH KAMATH KEmployeeSell5.0K₹14.9L298.8091.7K → 86.7K0.01%-0.00 pp7(2)told 20 Feb 2024
22 Feb 2024KIRAN KUMAR GANDHIRAJANEmployeeSell5.4K₹16.3L301.501.64L → 1.59L0.01%-0.00 pp7(2)told 20 Feb 2024
22 Feb 2024KIRAN KUMAR GANDHIRAJANEmployeeSell5.4K₹15.6L289.801.70L → 1.64L0.01%-0.00 pp7(2)told 20 Feb 2024
22 Feb 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.8L282.091.06L → 1.05L0.01%-0.00 pp7(2)told 20 Feb 2024
22 Feb 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.8L282.001.07L → 1.06L0.01%-0.00 pp7(2)told 20 Feb 2024
22 Feb 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.8L279.001.08L → 1.07L0.01%-0.00 pp7(2)told 20 Feb 2024
22 Feb 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.8L277.001.09L → 1.08L0.01%-0.00 pp7(2)told 20 Feb 2024
16 Feb 2024MANEESH H GHILDYALEmployeeSell1.0K₹2.7L271.051.10L → 1.09L0.01%-0.00 pp7(2)told 15 Feb 2024
16 Feb 2024MANEESH H GHILDYALEmployeeSell3.0K₹8.1L269.181.13L → 1.10L0.01%-0.00 pp7(2)told 15 Feb 2024
3 Jan 2024SARAVANAN KRISHNANEmployeeSell5.9K₹14.8L249.605.9K → —0.00%7(2)told 3 Jan 2024
28 Dec 2023MANEESH H GHILDYALEmployeeSell3.0K₹7.6L254.751.16L → 1.13L0.01%-0.00 pp7(2)told 28 Dec 2023
28 Dec 2023MANEESH H GHILDYALEmployeeSell2.0K₹5.0L249.681.18L → 1.16L0.01%-0.00 pp7(2)told 28 Dec 2023
28 Dec 2023MANEESH H GHILDYALEmployeeSell2.0K₹4.9L246.251.20L → 1.18L0.01%-0.00 pp7(2)told 28 Dec 2023
27 Dec 2023ARSHAD JAMILOtherSell5.0K₹12.6L251.0032.8K → 27.8K0.00%0.00 pp7(2)told 26 Dec 2023
22 Dec 2023KRISHNASAI TANNEERUOtherSell6.0K₹15.3L255.0032.5K → 26.5K0.00%0.00 pp7(2)told 21 Dec 2023
15 Dec 2023ARSHAD JAMILOtherSell15.0K₹36.7L244.6747.8K → 32.8K0.00%0.00 pp7(2)told 13 Dec 2023
7 Dec 2023VIJAY WAMAN GHOGAREOtherSell8.2K₹19.0L232.568.2K → —0.00%7(2)told 5 Dec 2023
7 Dec 2023SAURABH NARAINEmployeeSell10.0K₹23.5L234.7733.2K → 23.2K0.00%0.00 pp7(2)told 6 Dec 2023
3 Oct 2023ANUJ GOELOtherSell30.0K₹81.4L271.214.71L → 4.41L0.04%-0.00 pp7(2)told 30 Sept 2023
3 Oct 2023ANUJ GOELOtherSell20.0K₹53.3L266.694.91L → 4.71L0.04%-0.00 pp7(2)told 30 Sept 2023
28 Sept 2023ABHIJIT ZUTSHIEmployeeSell10.0K₹27.0L269.701.08L → 98.4K0.01%-0.00 pp7(2)told 28 Sept 2023
20 Sept 2023Atanu RoyOtherSell11.8K₹31.9L269.0011.8K → —0.00%7(3)told 19 Sept 2023
5 Sept 2023VIRUPAX TOPANNAWAROtherSell15.0K₹39.2L261.5018.3K → 3.3K0.00%0.00 pp7(2)told 5 Sept 2023
5 Sept 2023SIVANANDAM KOtherSell27.6K₹72.0L261.1334.9K → 7.3K0.00%0.00 pp7(2)told 4 Sept 2023
30 Aug 2023ARSHAD JAMILOtherSell5.0K₹12.0L240.0041.6K → 36.6K0.00%0.00 pp7(2)told 30 Aug 2023
30 Aug 2023VEENA VASANTHOtherSell6.0K₹15.6L260.2090.0K → 84.0K0.01%-0.00 pp7(2)told 30 Aug 2023
30 Aug 2023MANEESH H GHILDYALEmployeeSell2.0K₹5.2L259.401.24L → 1.22L0.01%-0.00 pp7(2)told 29 Aug 2023
30 Aug 2023MANEESH H GHILDYALEmployeeSell2.0K₹5.2L260.151.26L → 1.24L0.01%-0.00 pp7(2)told 29 Aug 2023
25 Aug 2023EPURI LAKSHMI NARAYANAOtherSell9.9K₹25.5L257.5810.1K → 2250.00%0.00 pp7(2)told 23 Aug 2023

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 14 Jul 2026

CSV
12 of 48 deals
By year
DateDealClientQuantityPriceValue
14 Jul 2026Sell · block, also bulkMYLAN INC.4.60Cr400.00₹1,839.3Cr
14 Jul 2026Buy · block, also bulkICICI PRUDENTIAL MUTUAL FUND1.84Cr400.00₹737.5Cr
14 Jul 2026Buy · blockHDFC MUTUAL FUND58.29L400.00₹233.2Cr
14 Jul 2026Buy · blockKOTAK MAHINDRA MUTUAL FUND58.29L400.00₹233.2Cr
14 Jul 2026Buy · blockSBI MUTUAL FUND18.75L400.00₹75.0Cr
14 Jul 2026Buy · blockADITYA BIRLA SUNLIFE MUTUAL FUND12.50L400.00₹50.0Cr
14 Jul 2026Buy · blockICICI PRUDENTIAL LIFE INSURANCECOMPANY LTD.12.50L400.00₹50.0Cr
14 Jul 2026Buy · blockFRANKLIN TEMPLETON MUTUAL FUND9.38L400.00₹37.5Cr
14 Jul 2026Buy · blockMIRAE ASSET MUTUAL FUND9.38L400.00₹37.5Cr
14 Jul 2026Buy · blockBNP PARIBAS ARBITRAGE7.50L400.00₹30.0Cr
14 Jul 2026Buy · blockCITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED7.50L400.00₹30.0Cr
14 Jul 2026Buy · block360 ONE MUTUAL FUND6.26L400.00₹25.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 8 Aug 2025 — P/E above 50 on the last four quarters’ earnings.

Price band: No band · not in the F&O ban · 46.7% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes · ban days · MWPL.

Every stock on this session →

Futures & options · 20 Nov 2026

CSV

Short covering — price up as positions closed — shorts buying back.

Futures OI
4.81Cr

₹1,753.2Cr

OI change
-1.15%
Basis
-0.32%
Rollover
81.0%
PCR (OI)
0.83
PCR (volume)
0.69
Front settle
363.30
Lot size
2,500

shares

Futures volume
11.9K

contracts

Futures trades
9,059
Futures value
₹1,085.7Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Option chain · 20 Nov 2026 · lot 2,500

Put OICall OI
Max pain
340

-6.7% from spot

Call OI wall
380
Put OI wall
310
PCR (OI, this expiry)
0.80
PutsStrikeCalls
305
310PW
315
320
325
330
335
340MP
345
350
355
360
Spot 364.45
365
370
375
380CW
385
390
395
400
405
410
420
430
480

340: puts 39.90L OI (−3.40L), close 0.15, ₹31.7Cr notional in 209 trades · calls 43.42L OI (−4.35L), close 23.20, ₹19.8Cr notional in 132 trades

Open interest in shares on the 20 Nov 2026 session, around the cash price. MP is max pain, the strike where option holders would collect least at expiry; CW and PW are the strikes above and below the price with the most open calls and puts. On expiry day the front is already the next expiry. Scan them with max_pain, call_oi_wall and put_oi_wall.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations3,953.73,917.13,432.93,590.43,821.44,417.03,941.94,295.54,173.04,516.64,336.04,388.9
Other income565.548.61,134.532.534.836.979.793.0117.352.554.534.5
Total income4,519.23,965.74,567.43,622.93,856.24,453.94,021.64,388.54,290.34,569.14,390.54,423.4
Total expenses3,708.13,635.23,453.93,550.53,718.43,987.53,924.74,205.34,064.74,241.24,249.44,361.9
└ Finance costs266.7227.0236.0225.6223.4212.4276.7272.2209.9231.5213.2240.1
└ Depreciation414.5407.0405.4419.9425.4436.3455.0473.0515.3513.4547.4563.8
Profit before tax832.3321.71,145.598.4155.9486.896.9171.3(67.8)247.5127.654.8
Tax expense54.996.1283.771.374.827.47.738.5(16.0)48.9(9.2)(1.9)
Net profit753.3222.9861.827.181.1459.489.2132.8(51.8)198.6136.856.7
EPS5.521.135.51-0.130.212.880.260.661.080.790.870.25
Net margin19.05%5.69%25.10%0.75%2.12%10.40%2.26%3.09%-1.24%4.40%3.15%1.29%
PBT margin21.05%8.21%33.37%2.74%4.08%11.02%2.46%3.99%-1.62%5.48%2.94%1.25%
Tax rate6.60%29.87%24.77%72.46%47.98%5.63%7.95%22.48%—19.76%-7.21%-3.47%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets52,042.854,576.956,070.757,127.958,797.362,759.863,650.665,279.5
Current assets12,334.014,069.915,179.215,153.516,286.218,781.117,179.818,010.0
└ Cash & equivalents1,323.5644.41,233.61,687.73,227.14,274.72,416.52,203.9
└ Other bank balances1,076.61,344.51,025.1406.7893.1326.4777.1218.5
└ Current investments1,326.51,797.3315.6555.9447.31,502.4689.8264.3
└ Trade receivables3,573.24,033.26,230.66,129.25,487.95,519.25,986.86,059.2
└ Inventories4,243.74,910.84,943.94,965.14,931.15,776.86,085.77,145.2
Total equity22,488.824,277.425,274.826,720.027,712.533,055.236,621.537,156.0
└ Attributable to owners17,866.918,982.419,783.720,993.221,644.026,803.634,031.834,842.8
└ Non-controlling interest4,621.95,295.05,491.15,726.86,068.56,251.62,589.72,313.2
└ Share capital600.3600.3600.3600.3600.3668.5810.5814.8
Borrowings17,770.717,823.815,729.616,149.817,755.515,907.714,824.715,110.1
└ Current2,480.22,816.52,797.24,168.35,350.15,337.74,078.44,083.2
└ Non-current15,290.515,007.312,932.411,981.512,405.410,570.010,746.311,026.9
Trade payables3,983.14,392.56,272.06,368.96,548.76,975.66,772.17,871.3
Current liabilities8,510.710,366.415,358.815,805.114,333.816,254.214,069.214,730.6
Total liabilities29,554.030,299.530,795.930,407.931,084.829,704.627,029.128,123.5
Net debt14,044.114,037.613,155.313,499.513,188.09,804.210,941.312,423.4
Debt / equity0.790.730.620.600.640.480.400.41
Current ratio1.451.360.990.961.141.161.221.22

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow1,852.5(377.5)2,953.9705.44,061.2803.41,994.0769.0
└ Capex(1,726.3)(900.2)(1,931.6)(900.9)(2,343.3)(919.5)(1,911.7)(839.0)
Free cash flow126.2(1,277.7)1,022.3(195.5)1,717.9(116.1)82.3(70.0)
Investing cash flow(14,281.8)(994.9)(1,004.5)966.2(234.1)(1,275.9)(2,082.1)(286.0)
Financing cash flow13,048.7487.5(2,332.7)(1,278.6)(1,854.0)1,403.1(923.6)(754.6)
└ Dividends paid(71.8)(203.0)(203.0)(82.9)(82.9)(90.8)(90.8)(105.6)
└ Buybacks(64.7)0.00.00.00.00.00.00.0
Net change in cash641.1(894.8)(380.4)403.12,004.3930.6(1,011.7)(271.6)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

BIOCON at a glance

  • BIOCON closed at ₹364.4 on 20 Nov 2026, +0.21% on the day, -11.4% over one year, 18.5% below its 52-week high of ₹447.15.
  • Delivery was 53.1% of traded quantity on 20 Nov 2026, the 92nd percentile of its own 3,629 sessions with a reading (20-session average 46.3%, 1-year average 48.8%).
  • Market capitalisation is ₹59,386 crore at a trailing P/E of 131.4 (trailing EPS ₹2.77).
  • Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹4,389 crore (+2.2% year on year), net profit ₹57 crore (-57.3%); the price moved +5.1% on the first session after.
  • Promoters held 44.68% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 21 Jan 2027 and 15 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE376G01013
SeriesEQ
Listed7 Apr 2004
NSE market cap · 17 Nov 2026₹58,571 Cr
Free-float market cap (NSE)₹24,981 Cr
Shares outstanding (NSE)162.97Cr
History from7 Apr 2004
Sessions5,613
Turnover rank#256

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.